W. L. Hanson

902 total citations
24 papers, 723 citations indexed

About

W. L. Hanson is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, W. L. Hanson has authored 24 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in W. L. Hanson's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Peptidase Inhibition and Analysis (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). W. L. Hanson is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (9 papers), Peptidase Inhibition and Analysis (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). W. L. Hanson collaborates with scholars based in United States, Japan and Canada. W. L. Hanson's co-authors include Eric T. Whalley, Wiltz W. Wagner, R. L. Capen, Lajos Gera, John M. Stewart, John S. Zuzack, S. E. Hofmeister, Dale Lien, G. Scott Worthen and Virginia E. Beckey and has published in prestigious journals such as Stroke, Journal of Applied Physiology and Journal of Medicinal Chemistry.

In The Last Decade

W. L. Hanson

23 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. L. Hanson United States 16 254 204 184 140 106 24 723
Danilo Croci Italy 17 190 0.7× 85 0.4× 265 1.4× 101 0.7× 42 0.4× 24 902
R W Colman United States 20 389 1.5× 125 0.6× 265 1.4× 175 1.3× 499 4.7× 32 1.3k
A. Genovese Italy 16 71 0.3× 127 0.6× 209 1.1× 390 2.8× 38 0.4× 56 940
Kenneth M. Wannemacher United States 12 44 0.2× 172 0.8× 226 1.2× 86 0.6× 442 4.2× 12 839
Nobuhiro Uyesaka Japan 16 250 1.0× 224 1.1× 169 0.9× 28 0.2× 233 2.2× 47 767
Harry B. Neustein United States 20 70 0.3× 86 0.4× 494 2.7× 36 0.3× 77 0.7× 33 1.2k
Kurt L. Berens United States 15 40 0.2× 116 0.6× 305 1.7× 171 1.2× 35 0.3× 30 1.1k
Imala Alwis Australia 13 64 0.3× 149 0.7× 290 1.6× 151 1.1× 326 3.1× 21 820
Hideo Ariyoshi Japan 19 35 0.1× 164 0.8× 570 3.1× 61 0.4× 225 2.1× 56 1.1k
Wenjie Xia China 22 112 0.4× 211 1.0× 238 1.3× 78 0.6× 28 0.3× 61 1.1k

Countries citing papers authored by W. L. Hanson

Since Specialization
Citations

This map shows the geographic impact of W. L. Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. L. Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. L. Hanson more than expected).

Fields of papers citing papers by W. L. Hanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. L. Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. L. Hanson. The network helps show where W. L. Hanson may publish in the future.

Co-authorship network of co-authors of W. L. Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of W. L. Hanson. A scholar is included among the top collaborators of W. L. Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. L. Hanson. W. L. Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hanson, W. L., Dona F. Boggs, J. M. Kày, et al.. (2000). Pulmonary vascular response of the coati to chronic hypoxia. Journal of Applied Physiology. 88(3). 981–986. 7 indexed citations
3.
Stewart, John M., Lajos Gera, Daniel C. Chan, et al.. (1997). Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications. Immunopharmacology. 36(2-3). 167–172. 18 indexed citations
4.
Whalley, Eric T., W. L. Hanson, John M. Stewart, & Lajos Gera. (1997). Oral activity of peptide bradykinin antagonists following intragastric administration in the rat. Canadian Journal of Physiology and Pharmacology. 75(6). 629–632. 15 indexed citations
5.
Stewart, John M., et al.. (1997). Potent, long-acting bradykinin antagonists for a wide range of applications. Canadian Journal of Physiology and Pharmacology. 75(6). 719–724. 41 indexed citations
6.
Whalley, Eric T., W. L. Hanson, John M. Stewart, & Lajos Gera. (1997). Oral activity of peptide bradykinin antagonists following intragastric administration in the rat. Canadian Journal of Physiology and Pharmacology. 75(6). 629–632. 13 indexed citations
7.
Relton, Jane K., Virginia E. Beckey, W. L. Hanson, & Eric T. Whalley. (1997). CP-0597, a Selective Bradykinin B2Receptor Antagonist, Inhibits Brain Injury in a Rat Model of Reversible Middle Cerebral Artery Occlusion. Stroke. 28(7). 1430–1436. 76 indexed citations
8.
Hanson, W. L., R. G. McCullough, William M. Selig, et al.. (1996). In vivo pharmacological profile of novel, potent, stable BK antagonists at B 1 and B2 receptors. Immunopharmacology. 33(1-3). 191–193. 27 indexed citations
9.
Goodfellow, Val S., W. L. Hanson, John S. Zuzack, et al.. (1996). Bradykinin Receptor Antagonists Containing N-Substituted Amino Acids:  In Vitro and in Vivo B2 and B1 Receptor Antagonist Activity. Journal of Medicinal Chemistry. 39(7). 1472–1484. 25 indexed citations
10.
Stewart, John M., Lajos Gera, W. L. Hanson, et al.. (1996). A new generation of bradykinin antagonists. Immunopharmacology. 33(1-3). 51–60. 83 indexed citations
11.
Hanson, W. L., Dona F. Boggs, J. M. Kày, S. E. Hofmeister, & Wiltz W. Wagner. (1993). Collateral ventilation and pulmonary arterial smooth muscle in the coati. Journal of Applied Physiology. 74(5). 2219–2224. 8 indexed citations
12.
Hanson, W. L., et al.. (1993). Pulmonary Capillary Recruitment in Neonatal Lambs. Pediatric Research. 34(5). 596–599. 1 indexed citations
13.
Lamm, W. J., et al.. (1991). Flow through zone 1 lungs utilizes alveolar corner vessels. Journal of Applied Physiology. 70(4). 1518–1523. 37 indexed citations
14.
Lien, Dale, G. Scott Worthen, R. L. Capen, et al.. (1990). Neutrophil Kinetics in the Pulmonary Microcirculation: Effects of Pressure and Flow in the Dependent Lung. American Review of Respiratory Disease. 141(4_pt_1). 953–959. 36 indexed citations
15.
Capen, R. L., W. L. Hanson, L. P. Latham, C. A. Dawson, & W. W. Wagner. (1990). Distribution of pulmonary capillary transit times in recruited networks. Journal of Applied Physiology. 69(2). 473–478. 19 indexed citations
16.
Yöder, Mervin C., et al.. (1990). Pulmonary microcirculatory kinetics of neutrophils deficient in leukocyte adhesion-promoting glycoproteins. Journal of Applied Physiology. 69(1). 207–213. 25 indexed citations
17.
Yamaguchi, Tetsu, Richard F. OʼBrien, W. L. Hanson, W. W. Wagner, & Ivan F. McMurtry. (1989). Prostacyclin contributes to inhibition of hypoxic pulmonary vasoconstriction by alkalosis. Prostaglandins. 38(1). 53–63. 20 indexed citations
18.
Dawson, C. A., R. L. Capen, L. P. Latham, et al.. (1987). Pulmonary arterial transit times. Journal of Applied Physiology. 63(2). 770–777. 12 indexed citations
19.
Wagner, Wiltz W., L. P. Latham, W. L. Hanson, S. E. Hofmeister, & R. L. Capen. (1986). Vertical gradient of pulmonary capillary transit times. Journal of Applied Physiology. 61(4). 1270–1274. 25 indexed citations
20.
Chapman, Willie L., W. L. Hanson, & L. D. Hendricks. (1983). Toxicity and Efficacy of the Antileishmanial Drug Meglumine Antimoniate in the Owl Monkey (Aotus trivirgatus). Journal of Parasitology. 69(6). 1176–1176. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danilo Croci Breakdown of academic impact, for papers by R W Colman Breakdown of academic impact, for papers by A. Genovese Breakdown of academic impact, for papers by Kenneth M. Wannemacher Breakdown of academic impact, for papers by Nobuhiro Uyesaka Breakdown of academic impact, for papers by Harry B. Neustein Breakdown of academic impact, for papers by Kurt L. Berens Breakdown of academic impact, for papers by Imala Alwis Breakdown of academic impact, for papers by Hideo Ariyoshi Breakdown of academic impact, for papers by Wenjie Xia
Rankless by CCL
2026